Julie E. Fischer
Dr. Julie Fischer joined CRDF Global in 2020 as its first Senior Technical Advisor for Global Health. Dr. Fischer brings over 20 years of global health experience in infectious disease research, laboratory systems strengthening, and public health preparedness to CRDF Global, where she directs the U.S. CDC portfolio.
Prior to joining CRDF Global, Dr. Fischer was an Associate Research Professor in the Department of Microbiology and Immunology and the Director of the Elizabeth R. Griffin Program at Georgetown University. She led a multidisciplinary team to promote evidence-based biosafety and biosecurity practices, and to help partner nations strengthen their capacities to detect and characterize disease threats rapidly, reliably, accurately, and safely. Before she joined Georgetown, Dr. Fischer held leadership positions at George Washington University’s Milken Institute School of Public Health and the Global Health Security Program at the Stimson Center. Dr. Fischer is the past Chair and current Communications Lead for the Global Health Security Agenda Consortium, a voluntary alliance of non-governmental institutions committed to strengthening global capacities to prevent, detect, and respond to biological events.
Dr. Fischer received a Ph.D. in Microbiology and Immunology from Vanderbilt University and completed postdoctoral training at the University of Washington and the Seattle Biomedical Research Institute.
Disarming Russia's Bioweapons Disinformation
Protecting Ukraine's laboratory infrastructure is crucial to prevent a health crisis
Revisiting the Origin Story of COVID-19
And why lab security in the age of COVID should be a priority
Laboratory Diagnostics—Rarely Appreciated Until Something Goes Wrong
Problems with COVID-19 testing highlights need for strong U.S. labs to detect, control, and respond to emerging diseases